Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Auerswald

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 12, 1999
German recommendations for immune tolerance therapy in type A haemophiliacs with antibodiesH H Brackmann, H Lenk, I Scharrer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2009
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentK Kurnik, C Bidlingmaier, W Engl, et al.
Klinische Padiatrie|March 23, 2013
Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for GermanyK Berger, D Schopohl, D Eheberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2013
No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective studyG Auerswald, A Bade, K Haubold, et al.
Lancet (London, England)|May 11, 1985
Inability of pasteurised factor VIII preparations to induce antibodies to HTLV-III after long-term treatmentJ Mösseler, K Schimpf, G Auerswald, et al.
Hamostaseologie|November 8, 2011
[Analysis of muscle function with kinetic superficial EMG in children with haemophilia - recognizing subclinical changes, establishing individual therapy, quality control]A Seuser, M Wendel, M Navarrete-Duran, et al.
Thrombosis and Haemostasis|April 1, 1995
Hepatitis C and pasteurised factor VIII and IX concentratesD Klarmann, W Kreuz, G Auerswald, et al.
Lancet (London, England)|June 3, 1995
Patient-to-patient transmission of hepatitis C virusD Klarmann, W Kreuz, K Auberger, et al.
Blood|August 12, 2000
Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)G Mariani, F H Herrmann, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assayJ Klinge, G Auerswald, U Budde, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 12, 1999
German recommendations for immune tolerance therapy in type A haemophiliacs with antibodiesH H Brackmann, H Lenk, I Scharrer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2009
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor developmentK Kurnik, C Bidlingmaier, W Engl, et al.
Klinische Padiatrie|March 23, 2013
Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for GermanyK Berger, D Schopohl, D Eheberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2013
No inhibitor development after continuous infusion of factor concentrates in subjects with bleeding disorders undergoing surgery: a prospective studyG Auerswald, A Bade, K Haubold, et al.
Lancet (London, England)|May 11, 1985
Inability of pasteurised factor VIII preparations to induce antibodies to HTLV-III after long-term treatmentJ Mösseler, K Schimpf, G Auerswald, et al.
Hamostaseologie|November 8, 2011
[Analysis of muscle function with kinetic superficial EMG in children with haemophilia - recognizing subclinical changes, establishing individual therapy, quality control]A Seuser, M Wendel, M Navarrete-Duran, et al.
Thrombosis and Haemostasis|April 1, 1995
Hepatitis C and pasteurised factor VIII and IX concentratesD Klarmann, W Kreuz, G Auerswald, et al.
Lancet (London, England)|June 3, 1995
Patient-to-patient transmission of hepatitis C virusD Klarmann, W Kreuz, K Auberger, et al.
Blood|August 12, 2000
Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)G Mariani, F H Herrmann, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 3, 2001
Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assayJ Klinge, G Auerswald, U Budde, et al.
Pageof 5